← Leaderboards
Alexander S Parker
Mayo Clinic Coll Of Med, Jacksonville
$2,386,840
Attributed
$2,386,840
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $384.9K · FY2006–22$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,386,840 · 4
By mechanism
R01$1,716,503 · 1
U54$294,145 · 1
R21$226,192 · 1
R03$150,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Med, Jacksonville
Same institution · by research overlap
- Christopher B Eckman$2,856,921
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseReportingFutureInstitutionResourcesEnsureNational Cancer InstituteEvaluationSuccessRenal Cell CarcinomaAnticancer ResearchResearch PersonnelCollaborationsAwardAlgorithmsAchievementCareer DevelopmentCharacteristicsDiagnostic Neoplasm StagingCaliforniaAccountabilityCommunitiesAdjuvant TherapyCancer Health Disparity
Grant awards (14)
PLANNING AND EVALUATION CORE$58,112
U54 · FY2022 · CA · contact PI
PLANNING AND EVALUATION CORE$61,628
U54 · FY2021 · CA · contact PI
PLANNING AND EVALUATION CORE$92,831
U54 · FY2020 · CA · contact PI
PLANNING AND EVALUATION CORE$59,779
U54 · FY2019 · CA · contact PI
PLANNING AND EVALUATION CORE$21,795
U54 · FY2019 · CA · contact PI
Design and Validation of a Biomarker-enhanced System to Predict RCC Progression$367,720
R01 · FY2014 · CA · contact PI
Design and Validation of a Biomarker-enhanced System to Predict RCC Progression$358,063
R01 · FY2013 · CA · contact PI
Design and Validation of a Biomarker-enhanced System to Predict RCC Progression$379,991
R01 · FY2012 · CA · contact PI
Design and Validation of a Biomarker-enhanced System to Predict RCC Progression$384,852
R01 · FY2011 · CA · contact PI
Design and Validation of a Biomarker-enhanced System to Predict RCC Progression$225,877
R01 · FY2010 · CA · contact PI
Type II TGF Beta Receptor and RCC Progression$111,432
R21 · FY2007 · CA · contact PI
Type II TGF Beta Receptor and RCC Progression$114,760
R21 · FY2006 · CA · contact PI
Differential Gene Expression in Renal Cancers$75,000
R03 · FY2004 · CA
Differential Gene Expression in Renal Cancers$75,000
R03 · FY2003 · CA